Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Neptune Wellness Solutions Inc. (NEPTF) vs PainReform Ltd. (PRFX)

Neptune Wellness Solutions Inc. and PainReform Ltd. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $3.0M against $1.6M — 1.8× the size. PainReform Ltd. has the higher net margin (0.00% vs −135.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, PainReform Ltd. leads on 7 and Neptune Wellness Solutions Inc. on 5.

Valuation

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m n/m 2.25
P/B n/m 0.00 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.99 12.29
EV/Sales 1.06 n/m 2.56
Earnings yield 0.00% (61,696.04%) (2.99%)
Free cash flow yield 0.00% (80,633.63%) 0.00%

Profitability

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Gross margin (1.94%) 0.00% 53.94%
Operating margin (190.39%) 0.00% 0.00%
Net margin (135.24%) 0.00% 0.00%
Free cash flow margin (40.57%) 0.00% 0.00%
Return on equity 291.47% 0.00% (0.40%)
Return on assets (121.62%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (24.78%) — 10.01%
EPS growth (last fiscal year) 67.05% 92.92% —
Revenue growth, 5-year CAGR 19.52% — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Debt to equity (0.50) 0.00 0.05
Current ratio 0.23 5.07 2.31
Net debt to EBITDA (0.21) 0.96 0.85

Dividend

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric NEPTF PRFX Drug Manufacturers Specialty & Generic median
Market cap 1.60m 2.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack